TIMKEN CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TIMKEN CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,670	3,004	3,581	3,790	3,513	4,133	4,497	4,769	4,573	4,582
Cost of revenue	1,964	2,192	2,541	2,648	2,503	2,984	3,165	3,260	3,132	3,189
Gross profit	706	812	1,040	1,142	1,010	1,103	1,288	1,509	1,441	1,393
Research and development	31.8	35.3	37.3	41.4
Selling, general and administrative	440	508	581	619	534	581	637	741	752	748
Operating income	244	300	455	516	455	513	607	657	611	541
Interest expense	33.5	37.1	51.7	72.1	67.6	58.8	74.6	111	125	110
Interest income	1.9	2.9	2.1	4.9	3.7	2.3	3.8	9.3	14.9	10.3
Other non-operating income	-0.9	9.6	9.4	13	-1.1	1.7	5.5	-1.2	-4.1	-8.8
Pre-tax income	285	361	533	472	396	477	551	531	494	416
Income tax	60.5	57.6	103	97.7	104	95.1	134	123	119	98.7
Income from continuing operations	141	203
Net income to minority interests	0.3	-1.1	2.7	12.6	7.9	12.4	9.6	13.9	22.6	28.9
Net income	141	203	303	362	285	369	407	394	353	288
EBITDA	376	437	601	677	622	681	771	858	833	771
EPS, basic	1.79	2.62	3.93	4.78	3.78	4.86	5.54	5.52	5.02	4.13
EPS, diluted	1.78	2.58	3.86	4.71	3.72	4.79	5.48	5.47	4.99	4.11
Shares, basic (weighted)	78.5	77.7	77.1	75.8	75.3	75.9	73.6	71.4	70.2	69.8
Shares, diluted (weighted)	79.2	78.9	78.3	76.9	76.4	77	74.3	72.1	70.8	70.2
Dividend per share	1.04	1.07	1.11	1.12	1.13	1.19	1.23	1.30	1.35	1.39

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	149	122	133	210	320	257	332	419	373	364
Short-term investments	11.7	16.4	21.8	25.8
Receivables	438	525	547	545	581	626	700	672	665	689
Inventory	554	739	836	842	841	1,043	1,191	1,229	1,196	1,243
Other current assets	48.4	81.2	77	105	106	150	124	129	103	119
Total current assets	1,212	1,500	1,737	1,875	2,000	2,214	2,504	2,635	2,517	2,601
Property, plant and equipment	804	864	912	989	1,036	1,055	1,207	1,312	1,307	1,358
Lease right-of-use assets			0	114	118	119	101	120	131	153
Goodwill	358	512	961	994	1,048	1,023	1,098	1,370	1,383	1,486
Intangible assets	271	421	733	759	741	669	765	1,031	1,007	1,002
Other non-current assets	34.9	25	37	1,996	21.5	23.9	25	29.9	25.8	23.6
Total assets	2,763	3,402	4,445	4,860	5,042	5,171	5,772	6,542	6,411	6,677
Accounts payable	176	265	273	302	351	430	404	367	322	353
Accrued liabilities	85.9	128	175	135	136	136	155	162	142	158
Deferred revenue						3.8	54.3	45.4	41.4	55.7
Short-term debt	5	2.7	9.4	64.7	131	53.8	49	606	13	38.9
Total current liabilities	453	672	686	737	848	897	1,012	1,471	821	922
Long-term debt	635	854	1,639	1,648	1,434	1,411	1,914	1,790	2,050	1,883
Lease liabilities			0	71.3	75.5	77.6	65.2	78.7	84	101
Other non-current liabilities	74.5	67.7	70.3	84	106	84.9	96.2	110	110	100
Total liabilities	1,452	1,928	2,803	2,905	2,816	2,793	3,420	3,839	3,427	3,331
Total debt	640	857	1,648	1,713	1,445	1,422	1,917	2,150	2,054	1,898
Paid-in capital	907	904	952	938	741	787	830	1,077	1,269	1,300
Retained earnings	1,289	1,408	1,630	1,907	1,340	1,616	1,932	2,232	2,489	2,679
Treasury stock	-892	-884	-960	-980	-9.3	-126	-352	-620	-671	-738
Other comprehensive income	-77.9	-38.3	-95.3	-50.1	41.3	-23	-182	-147	-302	-96.5
Shareholders' equity	1,280	1,443	1,580	1,868	2,153	2,295	2,268	2,582	2,827	3,185
Minority interests	31.2	32.2	63.1	86.6	72.3	82.8	84.6	120	158	161
Total equity	1,311	1,475	1,643	1,955	2,225	2,378	2,353	2,702	2,984	3,346
Total liabilities and equity	2,763	3,402	4,445	4,860	5,042	5,171	5,772	6,542	6,411	6,677

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	141	202	306	375	292	382	417	408	375	317
Depreciation and amortization	132	138	146	161	167	168	164	201	222	230
Stock-based compensation	14.1	24.7	32.3	27.1	23.2	20.2	30.4	30.6	25.9	28.3
Deferred income tax	-15	-0.4	-21.4	-8.9	-23.2	-15.1	-3.6	-11.6	-35.3	-27.2
Change in receivables	20.3	-42.3	-66.4	24.1	-20.7	-55.8	-73.5	71.6	-14.2	3.7
Change in inventory	10.1	-132	-87.1	50.7	27.4	-216	-146	72	9.6	-3.1
Cash from operations	404	237	333	550	578	387	464	545	476	554
Capital expenditures	-138	-105	-113	-141	-122	-148	-178	-188	-170	-148
Acquisitions	-72.6	-347	-765	-227	-24	-7.5	-454	-639	-167	0
Purchases of investments	-2.6	-3.6	-2.7	-4.1	-9.4	-18
Cash from investing	-211	-449	-865	-365	-154	-174	-573	-807	-305	-148
Debt issued	341	928	1,391	663	562	325	1,400	1,565	1,858	97.3
Debt repaid	-345	-685	-664	-634	-758	-338	-979	-1,329	-1,839	-366
Stock issued	4.3	32.9	12.8	27.5	37.4	26	8.5	21.8	5.6	1.9
Share buybacks	-101	-43.4	-98.5	-62.7	-49.3	-93	-212	-251	-40.5	-57.4
Dividends paid	-81.6	-83.3	-85.7	-84.9	-87	-92.2	-91.7	-94	-96.1	-98.3
Cash from financing	-169	168	553	-101	-331	-269	207	347	-195	-437
Exchange rate effect	-2.4	17.6	-12.7	-1.4	11.9	-7.4	-14.5	-7.2	-22	22.9
Net change in cash	21.7	-26.1	7.7	83.1	105	-63.2	82.8	78.6	-45.7	-8.2
Free cash flow	266	132	220	410	456	239	285	357	306	406
Income taxes paid	49.7	89.9	121	119	119	101	121	240	184	145

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $117.45 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	30.8%	Gross profit / revenue.
Operating margin	10.5%	Operating income / revenue.
EBITDA margin	15.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.0%	Pre-tax income / revenue.
Net margin	5.4%	Net income / revenue.
FCF margin	8.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.2%	Cash from operations / revenue.
Effective tax rate	25.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.8%	Net income / average total assets.
Return on invested capital (ROIC)	7.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	16.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.1%	Capital expenditures / revenue.
D&A / revenue	5.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	2.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-11.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-3.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	3.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-7.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-0.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	4.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-18.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-10.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	0.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-17.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-9.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	2.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	16.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	6.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	32.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	12.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-2.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	3.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	4.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	4.2%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	8.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.10x	Current assets / current liabilities.
Quick ratio	1.33x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.43x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.64x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	30.0%	Total debt / total assets.
Liabilities / assets	50.7%	Total liabilities / total assets.
Net debt	$1.65B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.24x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	4.81x	Operating income / interest expense.
Working capital	$1.92B	Current assets - current liabilities.
Goodwill and intangibles / assets	36.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$721.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.70x	Revenue / average total assets.
Fixed asset turnover	3.69x	Revenue / average property, plant and equipment.
Inventory turnover	2.64x	Cost of revenue / average inventory.
Days inventory	138 days	365 x average inventory / cost of revenue.
Receivables turnover	5.78x	Revenue / average receivables.
Days sales outstanding	63 days	365 x average receivables / revenue.
Days payables	41 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	160 days	Days inventory + days sales outstanding - days payables.
FCF conversion	149.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	27.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.69	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$67.92	Revenue / diluted weighted shares.
FCF per share	$5.50	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.57	Cash from operations / diluted weighted shares.
Book value per share	$45.58	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$10.29	Tangible book value / shares outstanding.
Cash per share	$5.69	(Cash + short-term investments) / shares outstanding.
Payout ratio	38.3%	Dividends paid / net income, when net income is positive.
Dividends / FCF	25.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	15.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$8.14B	Share price x shares outstanding.
Enterprise value	$9.79B	Market cap + total debt - cash - short-term investments.
P/E	31.5x	Market cap / net income. Only when net income is positive.
P/S	1.71x	Market cap / revenue.
P/B	2.55x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	11.3x	Market cap / tangible book value, when positive.
P/FCF	21.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	15.3x	Market cap / cash from operations, when positive.
EV/Sales	2.06x	Enterprise value / revenue.
EV/EBIT	19.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.3x	Enterprise value / EBITDA, when both are positive.
EV/FCF	25.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.7%	Free cash flow / market cap.
Earnings yield	3.2%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	2.0%	(Dividends paid + share buybacks) / market cap.

What was TIMKEN CO's revenue in fiscal 2025?

TIMKEN CO reported revenue of $4.58B for fiscal 2025, 0.2% higher than the year before.

Was TIMKEN CO profitable in fiscal 2025?

Yes. Net income was $288.4M, a net margin of 6.3%.

How much free cash flow did TIMKEN CO generate in fiscal 2025?

Cash from operations of $554.3M minus capital expenditures of $148.2M left free cash flow of $406.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TIMKEN CO